Modular Medical Announces Conference Call to Provide Business Update
Modular Medical Announces Conference Call to Provide Business Update
SAN DIEGO, CA / ACCESSWIRE / December 3, 2024 / Modular Medical, Inc. (the "Company" or "Modular Medical") (Nasdaq:MODD), an insulin delivery technology company with the first FDA-cleared patch pump designed specifically to target all adult "almost-pumpers" with its user-friendly and affordable design, today announced it will hold a conference call and webcast on Thursday, December 5, 2024, at 10:00 a.m. Eastern Time to provide a business update.
加州聖迭戈，2024年12月3日 /ACCESSWIRE/ 醫療器械公司Modular Medical, Inc.（簡稱"公司"或"Modular Medical"）(納斯達克: MODD)，一家擁有首款獲得FDA認可的貼片泵的胰島素輸送技術公司，專門針對所有成年"幾乎使用泵的人"，以其用戶友好和價格實惠的設計，今日宣佈將於2024年12月5日星期四東部時間上午10:00舉行電話會議和網絡直播，提供業務更新。
Conference Call and Webcast Information
Date: December 5, 2024
Time: 10:00 a.m. Eastern Time (7:00 a.m. Pacific Time)
Conference Call Number: 1-888-506-0062
International Call Number: +1-973-528-0011
Passcode: 494842
Webcast: CLICK HERE
電話會議和網絡直播信息
日期：2024年12月5日
時間：東部時間上午10:00（太平洋時間上午7:00）
電話會議號碼：1-888-506-0062
國際電話會議號碼：+1-973-528-0011
密碼：494842
網絡直播：點擊此處
For those unable to listen to the live Web broadcast, an archived webcast will be available on the Company's investor relations page at . A replay of the conference call will also be available through December 19, 2024, and can be accessed by calling 1-877-481-4010 and using passcode 51725. International callers should dial 1-919-882-2331 and enter the same passcode at the prompt.
對於那些無法收聽現場網絡廣播的人，公司的投資者關係頁面上將提供存檔的網絡廣播。 會議通話的重播將在2024年12月19日前提供，可通過撥打1-877-481-4010並使用51725作爲密碼來訪問。國際來電者應撥打1-919-882-2331並在提示時輸入相同的密碼。
About Modular Medical
關於醫療模塊化公司
Modular Medical, Inc. (Nasdaq:MODD) is a development-stage medical device company that intends to launch the next generation of insulin delivery technology. Using its patented technologies, the company seeks to eliminate the tradeoff between complexity and efficacy, thereby making top quality insulin delivery both affordable and simple to learn. Its mission is to improve access to the highest standard of glycemic control for people with diabetes taking it beyond "superusers" and providing "diabetes care for the rest of us."
Modular Medical, Inc.（納斯達克:MODD）是一家規劃推出下一代胰島素輸送技術的器械公司。利用其專利技術，公司旨在消除複雜性和功效之間的妥協，從而使高質量的胰島素輸送既負擔得起又易於學習。其使命是提高糖尿病患者獲得最高標準的血糖控制的途徑，超越"超級用戶"，爲"我們其他人"提供"糖尿病照護"。
Modular Medical was founded by Paul DiPerna, a seasoned medical device professional and microfluidics engineer. Prior to founding Modular Medical, Mr. DiPerna was the founder (in 2005) of Tandem Diabetes and invented and designed its t:slim insulin pump. More information is available at .
Modular Medical由經驗豐富的醫療器械專業人士和微流控工程師保羅·迪佩爾納創立。在創立Modular Medical之前，迪佩爾納先生於2005年創立了Tandem Diabetes，併發明和設計了其t:slim胰島素泵。 更多信息請訪問 .
All trademarks mentioned herein are the property of their respective owners.
這裏提到的所有商標均爲其各自所有者的財產。
CONTACT:
聯繫人：
Jeb Besser
Chief Executive Officer
Modular Medical, Inc.
+1 (617) 399-1741
IR@modular-medical.com
Jeb Besser
首席執行官
模塊化醫療公司
+1 (617) 399-1741
IR@modular-medical.com
SOURCE: Modular Medical, Inc.
來源：Modular Medical, Inc。
譯文內容由第三人軟體翻譯。
